Niquitin (Nicotine)

Nicotine, the active ingredient in Niquitin, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers who want to quit by reducing withdrawal symptoms and cravings associated with nicotine dependence.

GNH USA supplies Niquitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Niquitin is a nicotine replacement therapy used in the management of tobacco dependence and smoking cessation.

- Smoking cessation: provides controlled nicotine delivery to lessen cravings and withdrawal symptoms, supporting adults who are trying to quit smoking.

Side effects are generally related to the route of administration and systemic nicotine exposure.

Common Side Effects: - Skin irritation at the application site - Itching or redness where the patch is applied - Sleep disturbance, including insomnia - Vivid or abnormal dreams

Serious or Rare Side Effects: - Allergic skin reaction such as severe rash or swelling - Hypotension or rapid heart rate (tachycardia) - Signs of nicotine poisoning, e.g., nausea, vomiting, dizziness

Before using Niquitin, consider the following safety measures.

- Cardiovascular assessment: evaluate recent heart attacks or unstable angina - Avoid concurrent nicotine products: do not use cigarettes, gum, or lozenges while wearing the patch - Pregnancy and lactation: discuss risks with a healthcare professional before use - Keep out of reach of children: store securely to prevent accidental exposure - Store at room temperature: keep in the original packaging, protect from moisture and direct heat

Niquitin may interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Warfarin: nicotine may reduce anticoagulant effect, increasing clot risk - Monoamine oxidase inhibitors (MAOIs): combined use can raise blood pressure

Moderate Interactions (Monitor Closely): - Caffeine: nicotine can enhance stimulant effects, leading to jitteriness - Beta‑blockers: nicotine may diminish blood‑pressure‑lowering efficacy - Selective serotonin reuptake inhibitors (SSRIs): may increase the likelihood of side effects such as nausea